A comprehensive clinical-research unit focused on Frontotemporal Degeneration and related disorders, including Primary Progressive Aphasia (PPA), Semantic Dementia, Corticobasal Degeneration Syndrome (CBD), Progressive Supranuclear Palsy (PSP), Posterior Cortical Atrophy (PCA), FTD-ALS, and related disorders.

MGH Frontotemporal Disorders (FTD) Unit

Providing the highest quality of care while working tirelessly for a cure for Frontotemporal Dementia, Alzheimer’s Disease and related disorders.

Our Mission

The mission of the MGH FTD Unit is to improve understanding of Frontotemporal Dementia (FTD), Primary Progressive Aphasia (PPA), Posterior Cortical Atrophy (PCA), young-onset and atypical Alzheimer’s disease, amyotrophic lateral sclerosis with FTD, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and related disorders with the goals of finding a cure and providing comprehensive care of patients and families living with these conditions.

Impact of our Research

We perform a variety of research that we hope will contribute to a better understanding the FTD disorders:

Educational Resources

We are actively engaged in a number of educational efforts at the local, national, and international levels:

Participate in a Study

We are always looking for individuals who would like to participate in our efforts, whether they be patients, family members, interested individuals from the public…